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study was to design, implement and apply a novel dual-tracer infusion protocol to simultaneously measure glycogen
concentration and turnover. After reaching isotopic steady state for glycogen C1 using [1-13C] glucose administration,
[1,6-13C2] glucose was infused such that isotopic steady state was maintained at the C1 position, but the C6 position
reflected 13C label incorporation. To overcome the large chemical shift displacement error between the C1 and C6
resonances of glycogen, we implemented 2D gradient based localization using the Fourier series window approach, in
conjunction with time-domain analysis of the resulting FIDs using jMRUI. The glycogen concentration of 5.1W 1.6mM
measured from the C1 position was in excellent agreement with concomitant biochemical determinations. Glycogen
turnover measured from the rate of label incorporation into the C6 position of glycogen in the a-chloralose
anesthetized rat was 0.7mmol/g/h. Copyright  2009 John Wiley & Sons, Ltd.
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Glycogen (Glyc) is a macromolecule consisting of linked glycosyl
units that serves as a storage molecule for glucose (Glc) in the
body. Since it has a much lower concentration in the brain than in
tissues such as muscle and the liver, its role as a cerebral energy
store has been largely neglected, although over the last decade
interest has been renewed for several reasons: not only does it
appear to play an active role in brain energy homeostasis (1), it is
also involved in such processes as memory formation (2) and
neurotransmitter synthesis (3). Additionally, it has been impli-
cated in hypoglycemia unawareness, a dangerous complication
often encountered in patients treated with exogenous insulin (4).
Glycogen concentration and its changes are the result of the
simultaneous action of synthesis and catabolism (i.e. turnover),
which likely regulate the level of brain glycogen in the resting
state (1,5). In order to gain insight into the role of glycogen in the
abovementioned processes, it is important to determine its
concentration and metabolic rates.
Metabolism of glycogen can be assessed by measuring
the incorporation of its precursor glucose that has been labeled
with an isotope like 13C, 3H or 14C. From the time or rate of label
incorporation, turnover times or rates can be determined.
Currently, the only method to measure label incorporation into
glycogen non-invasively in vivo is 13C nuclear magnetic
resonance (NMR) (1). Following the infusion of isotopically
enriched (IE) [1-13C1] Glc, incorporation of
13C label into Glyc can
be measured (6). The IE of the infused glucose is close to 100% to
improve the signal-to-noise ratio (SNR) of the NMR measure-
ments of glycogen. However, such measurements of 13C label
incorporation may be due to increased Glyc IE or due to a net
increase in Glyc concentration.ed. 2010; 23: 270–276 Copyright  2009We have previously shown that the absolute concentration of
brain Glyc can be determined from the C1 resonance by
‘prelabeling’ with [1-13C] Glc, i.e. providing the animal exclusively
with food that only contains [1-13C] Glc as a source of carbon prior
to the experiment (7) to improve the SNR enough to allow the
measurement of the Glyc C1 signal. When the enrichment at C1
reached steady state, the IE of N-acetylaspartate (NAA) was used
to determine the IE of Glyc in vivo. This approach allowed the
measurement of the Glyc concentration while minimally perturbing
it (8), but provided no information on turnover.John Wiley & Sons, Ltd.
Figure 1. Diagram of the FOSSIL pulse sequence. The 908 BIR-4 pulse is
preceded by a 1D ISIS module for slice selection. The time between the
BIR-4 and the acquisitionwas 270ms, while the repetition timewas 10 s for
the phantom and 1 s for the rat.
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2However, if after this prelabeling [1,6-13C2] Glc is infused at the
IE of the Glyc C1 resonance, the C1 resonance will remain in
isotopic steady state and will act as a pure concentration change
monitor, while the C6 resonance signal will increasemostly due to
label incorporation, and can in principle be monitored to
determine the turnover time. The aim of the present study was
therefore to establish the simultaneous measurement of the
glycogen C1 and C6 resonances, such that the C1 resonance can
be used to determine concentration and the C6 resonance can be
used to determine the turnover time.
One of the challenges of measuring the Glyc C1 and C6
resonances simultaneously is that they are separated by 4 kHz
at 9.4 T due to their chemical shifts of 100.5 and 61.4 ppm
respectively. Such a large frequency difference represents a
formidable challenge for 3D spatial localization using gradient-
based methods, to date the only method capable of measuring
NMR of Glyc in the brain. To overcome chemical shift
displacement (CSD), one of the goals of the present study was
therefore to implement a new gradient-based localization
sequence that aimed to minimize CSD: the two-dimensional
Fourier series window (FSW, (9)).
Fourier series window (FSW) based pulse sequences have been
used mostly for 31P NMR in muscle and liver (10–12). The FSW is
an alternative to traditional Fourier transform chemical shift
imaging (CSI). A predetermined voxel shape is chosen for which a
single window W (the voxel) of resolution N is generated by
summation of 2Nþ 1 phase-encoded FIDs that are multiplied by
a series of matching Fourier coefficients bn (see Appendix for a
recapitulation of FSW theory).
The FSW localization approach can be tailored to achieve
arbitrary voxel shapes, has low cross-voxel contamination and a
complete lack of CSD (13). The number of repetitions per phase
encoded FID should correspond to the Fourier coefficient’s
relative weight; a phase encode with a low Fourier coefficient will
need only a few averages, while a high coefficient should imply
many averages for efficient performance. The FSW approach is
thus ideally suited for applications that require many averages as
is the case for 13C NMR of glycogen.
Therefore the aim of the present study was two-fold: first to
implement a localization scheme based on the 2D Fourier series
window to minimize CSD, and second to establish a dual-isotope
protocol using [1,6-13C2] glucose and to determine the Glyc
turnover time while monitoring its concentration under light
anesthesia.
METHODS
NMR instrumentation
All experiments were performed using an actively shielded
9.4 T 31 cm horizontal-bore Varian spectrometer with high-
performance gradients (400mT/m in 130ms). A custom-built
3-loop 10mm diameter surface coil was used for 13C excitation
and detection, while quadrature 14mm 1H coils were used for
positioning, shimming and decoupling (14). Shimming was
performed with FASTMAP (15).
FSW pulse sequence
The total delay for the gradients to play out between the
excitation pulse and the start of the acquisition was 270ms
(Fig. 1), which should result in less than 3% signal loss due to the
estimated glycogen T2 of 10ms (16). Slice selection in the thirdNMR Biomed. 2010; 23: 270–276 Copyright  2009 John Wileydimension was achieved using one-dimensional ISIS (17), using a
6ms hyperbolic secant pulse to select a slice of 1 cm thickness.
The ISIS localization is prone to signal reduction because of the
short relaxation times of glycogen; the Glyc signal reduction due
to ISIS was experimentally determined to be less than 10% in
1D localized volumes encompassing the entire sensitive volume
of the 13C RF coil. The gradient strength was set to 125mT/m,
which for the 13C gyromagnetic ratio of 10.7MHz/T is equivalent
to 13.4 kHz/cm. The chemical shift difference of 3.9 kHz between
the Glyc C1 and C6 resonances will therefore result in a chemical
shift displacement of 3.9/13.4¼ 0.3 cm. A minimum of two
averages was thus required per gradient setting. We propose the
acronym FOSSIL (Fourier Series-based Spectroscopic Imaging
Localization) for this 2D Fourier.
WALTZ-16 broadband NOE and decoupling were applied at the
1H water frequency (18). A 3ms 908 BIR-4 pulse (19) was used for
excitation, with a nominal bandwidth of 5 kHz at 2.5 kHz gB1max,
sufficient to cover the 3.9 kHz frequency difference between the
Glyc C1 and C6 resonances (Fig. 2). The 3ms BIR-4 pulse was
assessed to result in less than 4% Glyc signal reduction in
unlocalized spectra. The phase of the BIR-4 pulse increasingly
varies nearer to the edge of its nominal bandwidth.
The Fourier coefficients were calculated (see Appendix) for a
square two-dimensional Fourier series window in two dimensions
with a field of view (FOV) of 22 22mm2. For a window
resolution of 1/5 FOV (4.4 4.4mm2) and n¼ 5 coefficients this
resulted in (2Nþ 1)2¼ 121 phase encodes, while for 1/8 FOV
(2.75 2.75mm2) and n¼ 8 coefficients it resulted in 289 phase
encodes. Each of these phase encodes had its number of
acquisitions adapted to its 2D Fourier coefficient bn (Eq. A.5 in the
Appendix).
Validation of FSW localization in phantom experiments
To verify the localization accuracy of the FSW sequence, we used
a seven-compartment phantom, consisting of a water-filled
Perspex half-cylinder in which 6 tubes with different solutions
were mounted. The tubes contained saturated solutions of
either bicarbonate (of which the carboxyl carbon resonates
at 168.9 ppm), formate (174.0 ppm), carbonate (161.1 ppm) or
acetate (182.2 ppm).
The repetition time was set to 10 s as a compromise between
the long T1 relaxation time of the carboxyl groups (6–30 s) and
limited acquisition time. The average number of acquisitions per
gradient setting was 12, adjusted according to the relative
coefficient weight (see Appendix).& Sons, Ltd. www.interscience.wiley.com/journal/nbm
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Figure 2. Simulated characteristics of a 3ms 908 BIR-4 adiabatic pulse: a) resonance offset vs phase offset at different values of gB1max, with horizontal
markers at 4 kHz bandwidth. Not far outside the bandwidth, the relation becomes incoherent; b) resonance offset vs magnetization in the transverse
plane at 2.5 kHz; outside a bandwidth of roughly 4.5 kHz the flip angle becomes incoherent; c) pulse power vsmagnetization in the transverse plane. 2 kHz
gB1max appears to be sufficient power for all offsets.
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2In vivo measurements
To determine the brain Glyc turnover rates and concentrations,
six Sprague-Dawley rats (225 g, Charles River Laboratories,
France) were fasted overnight (Fig. 3). The next morning, 24 h
before the start of the NMR experiments, they were fed 100%
enriched, 10% w/v [1-13C1] Glc in tap water ad libitum to achieve
isotopic steady state for the Glyc C1 resonance (without
disturbing the Glyc concentration itself and in the case of
near-complete turnover) as described previously (7,8).
On the day of the NMR measurement, the animal was
anesthetized with 2% isoflurane. Both femoral veins and a
femoral artery were catheterized for infusion of glucose and
a-chloralose, and blood-gas analysis respectively. After surgery,
anesthesia was switched to a-chloralose (an initial bolus of
80mg/kg followed by continuous infusion of 50mg/kg/h
with 5mg/ml a-chloralose in saline) under assisted breathing,
considered relatively light anesthesia (20). The animal was then
placed in the NMR scanner where its temperature was kept at
37.5 0.58C with circulating warm water. While the animal was in
the scanner, blood samples were taken for blood-gas and
glycemia analysis every 30min to monitor physiology.
Glycogen NMR studies
Two sets of ‘baseline’ datasets with the FSW-based sequence
were acquired to determine the glycogen and glucose levels at
steady state. With a repetition time of 1 s (taking the Glyc T1 of
300ms at 9.4 T into account (16)), averaging of the phase
encodes at 5 coefficients per dimension for a 1/5 FOV window
(see Appendix) was calculated such that the total acquisition time
was 59min (see Appendix). The 13C carrier frequency was placed
in the center of the Glyc C1 and C6 resonances, while broadband
decoupling was applied at the Glc 1H frequency.
After these baseline acquisitions, a bolus of 0.6mg/kg
[1,6-13C2] Glc whose IE matched that of Glyc C1 was given over
5min, and a variable-rate infusion of [1,6-13C2] Glc was usedFigure 3. Overview of the experimental protocol and its timing. After
fasting, the animal is prelabeled with C13 Glc, prepared for the study and
inserted in the scanner, where its IE is determined. The main study itself
then starts and lasts until sacrifice. After the study a phantom is inserted
for absolute quantification purposes.
www.interscience.wiley.com/journal/nbm Copyright  200afterwards to maintain blood Glc level at 10mM. Seven more
5 5 FSW datasets were then acquired with a temporal
resolution of 1 h.
After the study, the animal was sacrificed using 2 s of focused
4 kW microwave radiation (Gerling Applied Engineering, Mod-
esto, CA). The brain was taken out and stored at 808C for later
biochemical determination of Glyc content and high resolution
NMR determination of Glyc IE.
A phantom containing 500mM Glyc (Sigma-Aldrich, St. Louis,
MO) and 5mM [1-13C] Glc was then placed under the coil at
T¼ 378C, and another set of 5 5 FSW was acquired for absolute
quantification purposes as described previously (7).
Isotopic enrichment
The IE of the steady state Glyc C1 position was determined in vivo
to match the IE of infused Glc to this IE and thus to keep the Glyc
C1 IE constant. Since the steady state IE of glycogen using this
protocol was empirically established to be 2.2 times that of
N-acetylaspartate (NAA) (7), the NAA IE was determined by
comparing the 13C-coupled 1H NAA doublet signals to that of the
12C-coupled 1H NAA singlet in a modified ACED-STEAM (21)
sequence as described previously (7).
Brain extract measurements
The extracted brains were homogenized and prepared for Glc
concentration measurement as well as verification of the IE as
previously described (8). Briefly, after powderizing the brain by
mortar and pestle, 200ml of 0.03M sodium acetate was added,
which was then homogenized with an ultrasonic processor.
The sample was divided into two aliquots, one of which was
incubated at 378C with a-1,4- a-1,6-glucosidase, which com-
pletely degrades the glycogenmolecule to glucose (22), while the
other was incubated with a saline solution. From the glucose
content measured in a glucose analyzer (GM7 Micro-stat, Analox
Instruments, London, UK), one aliquot effectively gave the
summed glucose and glycogen concentration, while the other
gave the free tissue glucose concentration. After filtering,
lyophilizing and resuspension in D2O, high-resolution
1H NMR
spectra of these samples were obtained at 600MHz. The ratio of
the 13C bound doublet and 12C-bound singlet were used to
calculate the IE of free glucose in one aliquot, and the
concentration-weighted average IE of Glc and Glyc in the other.
The free glucose IE was then used to calculate the Glyc IE from the
concentration-weighted average IE of Glc and Glyc using Eq. 3
from Ref. (7).9 John Wiley & Sons, Ltd. NMR Biomed. 2010; 23: 270–276
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The calculation of the localized FIDs from the coefficient
weighted individual FSW FIDs was done in MATLAB (The
Mathworks Inc., Natick, MA, USA) using Eq. A.3 in the Appendix.
The datasets were reconstructed into a grid of 16 16 to allow
the selection of an optimally positioned voxel for every study. The
resulting FIDs were subsequently DC corrected and multiplied
with a 15Hz exponential decay.
The localized FIDs were processed in the time-domain using
the jMRUI software package (23,24). A frequency filter was
applied to select the chemical shift range from 47–110 ppm.
A total of 10 signal components were fitted using AMARES
(Advanced Method for Accurate, Robust, and Efficient Spectral
fitting) (25): Glyc C1, Glc C1b, Glc C1a, glycerol C1, Glc C6, Glyc C6,
a peak each for glutamine C2, glutamate C2 and aspartate C2,
plus a term accounting for any residual DC offset. The linewidths
of glucose (C1a, C1b and C6) were constrained to be equal, and
the linewidths of Glyc C1 and C6 were constrained to be equal.
These constraints on Glyc C6 and Glc C6 allowed separate
quantification of the overlapping C6 resonances of Glc and Glyc.
Since the phase of each individual resonance was stable
throughout the experiment, the phase was estimated for each
animal from the summed time series; the phase however varied
along the spectrum due to the phase profile of the BIR-4
excitation pulse (Fig. 2a). To minimize the influence of the broad
baseline components, the first 10 data points of the signals were
weighted with a quarter-sine wave (25).Figure 4. The localization capacity of the FSW sequence: a) schematic
drawing of the 30mm wide and 52mm long half-cylindrical localization
phantom. The compartment diameters and solutions are: I. 6mm filled
with bicarbonate, II. 4mm filled with formate, III. 5mm filled with
carbonate IV. 6mm filled with acetate V. 4mm filled with bicarbonate
and VI. 4mm filled with formate. The detection coil was placed on top of
the phantom; b) Thresholded 13C FSW color maps of the different
resonances have been projected on top of a 1H gradient echo image.
From left to right the color maps are formate, carbonate and acetate, all
scaled to fit the same color range. The locations of the individual
compartments can be seen in the gradient echo image, as can parts
of the formic acid-filled bubble at the center of the coil. 2Quantitation and turnover calculation
Absolute concentrations of Glc C1, Glyc C1 and Glyc C6 were
calculated from the in vivo and phantom signals S, the signals of
the formic acid reference phantom in both situations (to correct
for RF loading) and a correction factor a for differences in NOE
and partial T1 relaxation as in previous studies ((26) and
references therein). This results in:
½Gliv ¼
SGl;iv
SGl;ph
SFA;iv
SFA;ph
a
1:1%
IEGl;iv
½Glph: (1)
Here the Gl and FA are glucose/glycogen and formic acid, while iv
and ph are in vivo and phantom.
A basic model consisting of Glyc, Glc and their intermediary
glucose-6-phosphate (G6P) was used to model the Glyc C6
labeling time course. It was assumed that labeled Glc increased
stepwise at t¼ 0, that there was no Glyc label at t¼ 0 (1.1%
natural abundance neglected) and that the Glyc concentration
does not change over time. The corresponding set of differential
equations was then solved for the C6-labeled Glyc concentration
over time C(t) as described in Ref. (27), which resulted in:
CðtÞ ¼ Glyc½ C6 1 exp t=t½ ð Þ; (2)
where [Glyc]C6 is the steady state Glyc C6 concentration and t is
the Glyc turnover time. This equation was then used to fit the Glyc
C6 time course.
The Glc C1 and Glyc C1 time courses were fitted to a linear
curve. If the slope of the curve was more than an order of
magnitude lower than its fitting error, the time course was fitted
with a constant instead. All time courses were fitted with
OriginPro (OriginLab Corporation, Northampton, MA, USA).NMR Biomed. 2010; 23: 270–276 Copyright  2009 John WileyRESULTS
The localization ability of the 2D FSW sequence was tested on a
phantom containing bicarbonate, formate, carbonate and
acetate (Fig. 4). Despite the range of 20 ppm in chemical shift,
the FSW signals of a formate, carbonate and acetate compart-
ment overlap with their 1H image equivalents, as evidenced from
the FSW color maps of the resonances projected on top of a
1H gradient echo image (Fig. 4b). Note that the compartments
that were more than 10mm away from the surface coil plane
were outside the sensitive volume of the small 13C coil and thus
not detected.
Localization of the 2D FSW sequence was further tested in vivo.
Since it is well established that 13C resonances from lipids
originate outside the brain, good localization should eliminate
lipid-specific resonances. When placing the voxel of interest (VOI)
into superficial regions encompassing fat and muscle, clear
resonances ascribed to extra-cerebral fat (glycerol C1,3 at
62.5 ppm) were detected (Fig. 5b). Moving the VOI into the
brain minimized the glycerol resonance (Fig. 5c).
The bandwidth of the BIR-4 pulse was 5 kHz, sufficient to
simultaneously excite the Glyc C1 and C6 resonance with less
than 10% signal loss (compensated for in the absolute& Sons, Ltd. www.interscience.wiley.com/journal/nbm
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Figure 5. Demonstration of the FSW sequence localization capability: a) 1H gradient echo image with the same FOV size as the FSW sequence
(22 22mm2) and the positions of two windows indicated with white rectangles; b) example of a localized spectrum in the brain. Note the presence of
cerebral metabolites and the large Glc/Glyc peak; c) localized spectrum outside the brain; in this case in the skin. Notice that the relative contribution of
the glycerol is much bigger than that of Glyc and Glc C6, which still has a small presence due to the partial location of the voxel in the brain.
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4quantification procedure), according to simulations (Fig. 2) and
verified in phantom studies. Since the RF coil’s RF loading varied
per subject, the effective power for the 908 BIR-4 RF pulse was
varied slightly each time, causing the zero and first order phase of
the spectra to vary slightly from study to study, as expected from
the pulse profile (Fig. 2b). Therefore, while the magnitude of the
excited signal for the resonances of interest was comparable
across all studies, the phase over the entire spectrum varied up to
708. In particular, the phase of the Glyc C1 and Glyc/Glc C6
resonances, while stable per subject, showed large variations
across subjects. Nonetheless, the SNR of the localized spectra was
in all cases high enough to allow robust fitting using the
time-domain AMARES fitting routine, including the aforemen-
tioned phase variations, resulting in negligible residuals over the
spectral regime of interest (Fig. 6).
The time courses of the Glyc and Glc C1 signal were within
experimental error constant, consistent with the isotopic
steady-state achieved using this protocol (Fig. 7). For the
quantitation, both C1 resonances were corrected for the IE
(measured from NAA as in our previous study), which was
established at IEGlyc,inv¼ 42 6%. The in vivo IE determination
was within a few percent comparable to that in brain extracts
(as previously, (7)): a linear fit through the origin resulted
in IEGlyc,invivo¼ 1.03  IEGlyc,highres (R2¼ 0.98, p¼ 0.16).
From the thus determined IE of Glyc and the [1-13C] Glyc
concentration measured by in vivo NMR, the total concentrationFigure 6. jMRUI fitting of a FSW brain spectrum after 6 h of infusion. Bottom: s
Image: location of the window within the brain, with a formic acid phantom
www.interscience.wiley.com/journal/nbm Copyright  200of glycogen and glucose was calculated using Eq. 1, resulting in
total Glc and Glyc concentrations of [Glc]t,C1¼ 4.3 1.0 and
[Glyc]t,C1¼ 5.1 1.6mM respectively. Here the subscript t stands
for total, while C1 indicates that the concentration was based on
the integral of the C1 resonance. The determined glycogen
concentrations were, within experimental error, identical to that
determined by concomitant biochemical assays, which yielded
[Glyc]t,assay¼ 5.3 1.6mM.
The Glc C6 signal increased in a step-like manner to reach
steady state levels within 30min after the start of the [1,6-13C2]
Glc infusion at t¼ 0, whereas the Glyc C6 signal slowly
increased over time. Given that the stability of Glyc C1 indicated
minimal concentration changes, this gradual increase in the
Glyc C6 signal therefore mainly represents changes in the IE of
Glyc C6, and thus can be used to estimate glycogen turnover
time.
An exponential fit of the Glyc C6 signal with Eq. 2 resulted in a
turnover time of 8 4 h (R2¼ 0.97) and a steady state Glyc C6
concentration of [Glyc]C6¼ 3 1mM. Dividing the steady state
concentration of the Glyc C6 time course by its IE (assuming the
same C6 IE at steady state as the C1 resonance) resulted in a total
glycogen concentration [Glyc]t,C6¼ 7 3mM. By dividing the
average [Glyc]t by t we calculated a Glyc turnover rate of
0.7 0.6mmol/g/h. Constraining [Glyc]C6 to the Glyc C1 concen-
tration ([Glyc]t,C1
IE¼ 5.30.41¼ 2.2mM) and fitting the same
function resulted in t¼ 5.2 0.4 h.pectrum and fit. Middle: individual peaks with their names. Top: fit residual.
visible at the center of the detection coil.
9 John Wiley & Sons, Ltd. NMR Biomed. 2010; 23: 270–276
Figure 7. Time courses of the Glyc and Glc resonances; a) the total Glyc concentration as calculated from the C1 resonance (circles) with its linear fit, as
well as the increasing concentration of Glyc that is labeled at the C6 resonance (squares); b) The total Glc concentration as calculated from the C1
resonance (circles; scale on the left side) as well as the Glc C6 resonance signal strength (scale on the right side). Note that the Glc C6 is not quantified and
thus has an arbitrary scale. All errors bars are SD over the different animals.
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2DISCUSSION
In this study we implemented and used the FSWapproach for the
first time for 2D localization of 13C signals, which, combined with
a novel dual isotope infusion protocol, allowed the simultaneous
determination of Glyc concentration and turnover.
While the dephasing that the phase encoding generates
implies that the 2D FSW pulse sequence is theoretically not as
efficient as single-voxel localized spectroscopy, the sequence
does have the same efficiency equivalent to conventional
spectroscopic imaging, provided that the amount of acquisitions
per gradient setting are weighted by their Fourier coefficient.
Therefore, the SNR per time unit observed in the present study
was 70% that of single-voxel 13C spectroscopy studies (7,18).
The sequence appears to be a suitable alternative for regular
spectroscopic imaging or localized spectroscopy if large chemical
shift ranges are to be localized, provided sufficient averaging is
performed.
Time-domain fitting of the spectra was robust: the phase
variations across the chemical shift of the FSW spectra were
expected from the simulations of the BIR-4 pulse and were easily
accounted for by the AMARES routine. The step-like increase of
Glc C6 at the start of the infusion together with the slow increase
of Glyc C6 over time indicated that their resonances were
robustly deconvolved based on their substantially different
linewidths, despite Glyc and Glc C6 having considerable spectral
overlap.
The 2D FSW pulse sequence was combined with the IE
determination and external reference quantification to obtain
absolute quantifications of Glyc. IE determination was in excellent
agreement with previous results (7,26), and the in vitro
biochemistry and high resolution 1H NMR confirmed the validity
of the in vivo method.
The absolute quantification of the C1 resonance resulted in
total Glc and Glyc concentration time that were constant over
time, indicating stable Glyc and Glc concentrations, the former
validated by biochemical in vitro analysis and in agreement with
previously reported levels under similar hyperglycemic and
anesthetic conditions (8). Due to the slightly hyperglycemic level
at which the blood glucose was maintained, a slight increase in
the Glyc concentration over time could also have been expected.NMR Biomed. 2010; 23: 270–276 Copyright  2009 John WileyThis was, however, not observed, which may be due to SNR being
too low to detect such a small increase: a linear Glyc C1 time
course fit in which the slope was left free resulted in a slope of
8 104 0.25mM/h, showing that a glycogen concentration
increase of at least 0.5mM/h was necessary to be statistically
significant.CONCLUSIONS
We conclude that a) Glyc C1 and C6 can be simultaneously
measured in vivo using the FSW based pulse sequence, and that
b) the dual isotope infusion protocol proposed can be used to
simultaneously determine both the Glyc concentration and
turnover in vivo.Acknowledgements
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The FSW approach has in NMR mostly been used for
31P spectroscopic imaging. A more in-depth treatment of the
theoretical background can be found in Refs (9,11,13,28). For
convenience, a short overview of this theory is given in this
appendix.
In a one-dimensional FSW pulse sequence a predetermined
window shape W (the voxel) is chosen with a resolution N and
window width FOV/N. A phase encoding gradient is applied to
the transverse magnetization such that distance becomes
equivalent to the phase w. The window itself can then be
described as a set of 2Nþ 1 Fourier coefficients bn such that in the& Sons, Ltd. www.interscience.wiley.com/journal/nbm
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6one-dimensional case it looks like (9):
Wð’Þ ¼
XN
N
bne
in’: (A.1)
To determine the coefficients bn, one can reverse Eq. A.1 and
integrate from p to p:
bn ¼
1
2p
Z
d’Wð’Þein’: (A.2)
To avoid repeating the window inside the FOV, the first
coefficient b1 is set to have an accompanying phase encoding
step which has a phase spread of 1808 over the FOV. When
applied to the spatially encoded MR signal rð r*; tÞ, the window is
convolved with a series of phase-encoded FIDs S(n,t):
Z
dr
*
rðr*; tÞWð’Þ ¼
XN
N
bnSðn; tÞ: (A.3)
The window can be arbitrarily shifted a distance c by
multiplying the window with einc (i.e. Fourier shifting). The
windowed spatially encoded time-domain signal is now:
Z
dr
*
rðr*; tÞWð’þ cÞ ¼
Z
dr
*
rðr*; tÞ
XN
N
bne
inðcþ’Þ
" #
¼
XN
N
bnSðn; tÞeinðcÞ:
(A.4)
With these equations the parameters for the window of choice
can be calculated. In these studies, a square window shape was
chosen, so Eq. A.2 was solved for the square shape with width w,
resulting in 1D coefficients bn:
bn ¼
sinðnw=2Þ
np
: n ¼ N;Nþ 1; . . . ; 0; . . .N 1;N (A.5)
The 2Nþ 1 coefficients for the phase encoding combinations
can now be calculated. N is usually chosen such that the
resolution is FOV/N. The resulting voxel is only approximately
rectangular due to truncation by the finite number of coefficients.
However, terminating the coefficient function of Eq. A.4 at the
first zero crossing (i.e. where n¼2p/w) substantially reduces
any truncation effects (28). The shape of the window results in a
slightly larger area than its nominal width, yet 99% of the window
intensity drops off at 1.4 times the window width. The 2D FSW
separately applies the above equations to the second dimension
coefficients bm as well, resulting in (2Nþ 1)2 doubly weighted
phase encodes.REFERENCES
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